Serina TherapeuticsSER
13F holders, Q1 2024 (March 31)13holders
$13.46avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Serina Therapeutics Inc. (SER) in their 13F filings. The largest holders were Broadwood Capital Inc. ($1.1M), Vanguard Group Inc. ($269K) and BlackRock Inc. ($48K).
- Company
- Serina Therapeutics Inc.
- CUSIP
- 81751A108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $1.5M |
| Exits | 0 | $0 |
Ownership 13 holders
| Broadwood Capital Inc. | 0.09% | New | 85,219 | $1.1M |
| Vanguard Group Inc. | 0.00% | New | 19,951 | $269K |
| BlackRock Inc. | 0.00% | New | 3,530 | $48K |
| Citigroup Inc. | 0.00% | New | 656 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 448 | $6K |
| Wells Fargo & Company | 0.00% | New | 58 | $781 |
| Riggs Asset Managment Co. Inc. | 0.00% | New | 24 | $324 |
| Morgan Stanley | 0.00% | New | 10 | $135 |
| Albion Financial Group | 0.00% | New | 8 | $108 |
| Osaic Holdings, Inc. | 0.00% | New | 7 | $89 |
| UBS Group AG | 0.00% | New | 5 | $67 |
| BNP Paribas Financial Markets | 0.00% | New | 2 | $27 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $13 |
"% of holder's portfolio" is SER's weight in each manager's 13F, not the share of Serina Therapeutics Inc. the manager owns.